SCHEMBL22928007

SCHEMBL22928007

CC(C)(C)c1cccc(NS(=O)(=O)CC2CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHA3 P29320 1/20 0.43
FRK P42685 1/20 0.43
MAPK14 Q16539 1/20 0.43
RORC P51449 1/20 0.42
BRS3 P32247 1/20 0.42
GAK O14976 1/20 0.42
STK16 O75716 1/20 0.42
AAK1 Q2M2I8 1/20 0.42
BMP2K Q9NSY1 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
IKBKB O14920 1/20 0.41
UQCRB P14927 1/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22928004 0.94 ACLY (0.42) EPHA3FRKMAPK14RORCBRS3
SCHEMBL8274370 0.82 NR3C2 (0.57) RORCHDAC3HDAC8HDAC6IKBKB
SCHEMBL22928006 0.78 EPHX2 (0.48) BRS3AAK1HDAC3HDAC8HDAC6
SCHEMBL16658362 0.78 RORC (0.47) RORCHDAC3HDAC8HDAC6IKBKB
SCHEMBL22619046 0.78 GAK (0.44) GAKSTK16AAK1BMP2KCA1
SCHEMBL22928261 0.77 CYP3A4 (0.48) RORCHDAC3HDAC8HDAC6IKBKB
SCHEMBL17404464 0.76 ACLY (0.46) GAKSTK16AAK1BMP2KCA1
SCHEMBL16658363 0.75 BRD4 (0.49) RORCIKBKBUQCRBALDH1A1LMNA
SCHEMBL22928012 0.75 EPHX2 (0.44) BRS3GAKSTK16AAK1BMP2K
SCHEMBL4403147 0.75 NR3C2 (0.54) HDAC3HDAC8HDAC6IKBKBUQCRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF MEDICONNS SHANGHAI BIOPHARMACEUTICAL CO LTD (CN) 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF PRLHR, DRD2, AVPR2 EPHA3 4585/4885FRK 3478/4885MAPK14 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.